Informal payments for health care are common in most former communist countries. This paper explores the demand side of these payments in Albania. Using tobit and Heckman selection models we control for individual determinants of informal payments in outpatient and inpatient health care....

We examine the institutions that comprise the American health system and their relationship to a surging immigrant population. The clash between the system and this human flow originates in the large number of immigrants who are unauthorized, poor, and uninsured and, hence, unable to access a...

This paper has attempted to identify characteristic patterns of performance in tax-financed (TF) systems, contrasting them with systems relying more heavily on other revenue sources.

Over the past decade, the 'pharmacoeconomics' phenomenon has incited a stream of commentaries about the economic evaluation of drugs, conflicts of interest and ways of retaining respectability for this component of health economics profession. Private coporations now finance so many aspects of...

Quebecers are carrying a $682 billion fiscal burden – the higher tax bill for increased healthcare costs over the next half-century – and should prepare now for the coming demographic squeeze, says a report released today from the C.D. Howe Institute. In “An Aging Population Fiscal...

The article is based on qualitative research carried out by the authors at the seven Psychosocial Care Centers for Alcohol and other Drugs (CAPS AD) in the Federal District, in order to observe the implementation of the Ministry of Health Policy for Comprehensive Care for Users of Alcohol and...

In response to rapidly rising pharmaceutical costs, many countries have introduced health technology assessment (HTA) as a 'fourth hurdle'. We evaluated the causal effect of HTA based regulation on access to pharmaceuticals by using the introduction of Germany's HTA system (AMNOG) in 2011. We...

In response to rapidly rising pharmaceutical costs, many countries have introduced health technology assessment (HTA) as a 'fourth hurdle'. We evaluated the causal effect of HTA based regulation on access to pharmaceuticals by using the introduction of Germany's HTA system (AMNOG) in 2011. We...